Ptc Therapeutics (PTCT) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $6.5 million.
- Ptc Therapeutics' Other Non Operating Income rose 44732.91% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 10252.61%. This contributed to the annual value of $6.5 million for FY2024, which is 10475.73% up from last year.
- Per Ptc Therapeutics' latest filing, its Other Non Operating Income stood at $6.5 million for Q3 2025, which was up 44732.91% from -$5.7 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Other Non Operating Income ranged from a high of $35.1 million in Q4 2022 and a low of -$128.7 million during Q4 2023
- Moreover, its 5-year median value for Other Non Operating Income was -$5.7 million (2025), whereas its average is -$12.8 million.
- Per our database at Business Quant, Ptc Therapeutics' Other Non Operating Income crashed by 118381.7% in 2022 and then surged by 44732.91% in 2025.
- Ptc Therapeutics' Other Non Operating Income (Quarter) stood at -$31.4 million in 2021, then soared by 212.02% to $35.1 million in 2022, then plummeted by 466.24% to -$128.7 million in 2023, then skyrocketed by 106.88% to $8.8 million in 2024, then fell by 26.53% to $6.5 million in 2025.
- Its Other Non Operating Income stands at $6.5 million for Q3 2025, versus -$5.7 million for Q2 2025 and -$6.3 million for Q1 2025.